Nexus (NXU.DE) Osake Kurssi
Nexus Kurssi
Liikevaihto on kasvanut 14,2 % vuodessa viimeisten 19 vuoden aikana 261,46 M EUR:een. Osakekohtainen tulos on kasvanut 27,0 % vuodessa viimeisten 19 vuoden aikana. Nexusn nettomarginaali on nyt 11,8 %, noussut 9,2 %:sta muutama vuosi sitten. Nexusn osinkotuotto on tällä hetkellä noin 0,31 %. Jakosuhde on noin 12 % tuloksesta. Osinko on kasvanut 6,8 % vuodessa viimeisten 12 vuoden aikana.
Nexus osakekurssi
Nexus liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Nexus -osakkeesta
Nexus AG is primarily present in a wide range of countries and regions. With its strong global footprint, Nexus AG operates in various locations, including but not limited to Germany, Austria, Switzerland, and the United States. The company's commitment to expanding its presence internationally has allowed it to establish a strong market position and cater to a diverse customer base. Nexus AG's extensive reach demonstrates its dedication to providing innovative solutions and services to clients across different regions, strengthening its position as a leading player in the stock market industry.
Nexus AG is a leading software provider in the healthcare industry. The company's business model revolves around offering innovative and comprehensive solutions for medical facilities and organizations. Nexus AG develops and implements software applications for managing patient data, electronic health records, and administrative processes. By integrating various healthcare systems, Nexus AG streamlines workflows, enhances efficiency, and improves patient care. With its strong focus on research and development, Nexus AG continuously strives to deliver cutting-edge technologies and support the digital transformation of healthcare institutions. This commitment to excellence has established Nexus AG as a trusted partner for the healthcare sector worldwide.
Nexus AG is primarily active in the healthcare industry.
The main competitors of Nexus AG in the market include companies such as ABC Corporation, XYZ Holdings, and DEF Enterprises. These companies operate in the same industry and provide similar products and services, thereby competing with Nexus AG for market share. Nexus AG, however, maintains a strong competitive advantage through its innovative solutions, superior customer service, and proven track record in the industry. As an industry leader, Nexus AG continues to strive for excellence and stay ahead of its competitors by constantly adapting to market trends and offering cutting-edge technologies to its customers.
Nexus AG is a renowned company in the stock market, known for its rich history and robust background. Established in (year), Nexus AG has consistently excelled in delivering exceptional services and products to its clients. With a strong emphasis on innovation and customer satisfaction, Nexus AG has become a market leader in (specific industry), revolutionizing the way (specific field) operates. The company's success can be attributed to its talented team and strategic partnerships, which have contributed to its continuous growth. Nexus AG's commitment to excellence and forward-thinking approaches have positioned it as a trusted name within the stock market, making it a promising investment opportunity.
Nexus AG, a renowned company in the stock market, has successfully achieved several significant milestones. With their unwavering commitment to innovation and excellence, Nexus AG has emerged as a leader in the industry. Some notable milestones include the development of cutting-edge technologies, expansion into new markets, impressive revenue growth, strategic partnerships, and the accumulation of a loyal customer base. Nexus AG continues to strengthen its position and drive success through their continuous efforts and forward-thinking approach. With their focus on delivering top-quality products and services, Nexus AG remains a dominant force in the stock market.
Nexus AG is a leading software solutions provider, focusing on the healthcare industry. The company represents core values such as innovation, quality, and customer-centricity. With a strong corporate philosophy centered around improving patient care and optimizing healthcare processes, Nexus AG offers innovative software solutions that streamline and digitize healthcare workflows. Through their cutting-edge technology and commitment to excellence, Nexus AG empowers healthcare organizations to enhance efficiency, improve patient outcomes, and ensure data security. With a dedication to continuous improvement and forward-thinking, Nexus AG remains a trusted partner for healthcare institutions striving for excellence in an ever-evolving industry.
7 analyytikkoa arvioi tällä hetkellä Nexus-osaketta: 0 suosittaa ostoa, 3 pitoa ja 4 myyntiä. Vuodelle 2026 analyytikot odottavat Nexus-yhtiöltä 326,15 M EUR liikevaihtoa ja 2,36 EUR osakekohtaista tulosta.
Nexus-osake (NXU.DE) on listattuna 10 pörssissä, muun muassa: London (0FGL.L), SIX (Zürich) (NXU.SW), XETRA (NXU.DE), Frankfurt (NXU.F), München (NXU.MU), Stuttgart (NXU.SG), Düsseldorf (NXU.DU), Berlin (NXU.BE).
Nexus AG is a German company specializing in innovative software solutions and services in the healthcare industry. They offer solutions to support and improve workflow and data processing in the healthcare sector. Their divisions include eHealth, clinic IT, and security solutions. They provide applications for data networking in healthcare, such as electronic patient records (EPA) and a health information exchange (HIE) platform. Their clinic IT solutions range from patient data administration to clinical process management. They also offer comprehensive IT security solutions to protect patient data. Nexus emphasizes the importance of collaboration and partnerships in the healthcare industry.
odotettu liikevaihto Nexus on 326,15 M EUR. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Nexus on 40,74 M EUR. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Nexus:n hinta-voitto-suhde (P/E) on tällä hetkellä 30,18. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Nexus-osakkeen arvostusta.
Nexus:n hinta-myynti-suhde (P/S) on tällä hetkellä 3,77. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Nexus-osakkeen arvostuskennuslukuna.
Nexus:n Eulpool-laatuscore on 8/10.
Nexus:n ISIN on DE0005220909. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Nexus:n WKN on 522090. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Nexus:n ticker on NXU.DE. Tämä pörssinoteeraus käytetään Nexus-osakkeiden kauppaan pörssissä.
Nexus osake
Nexus vertaisryhmä
Nexus Ticker
Nexus FIGI
Kaikki tunnusluvut ja syvällinen analyysi Nexus:sta
Meidän osakeanalyysimme Nexus-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Nexus:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: